Showing results (51-60 of 269) with videos related to

Sort By:
Pageof 27
Journal of the American Society of Nephrology : JASN|November 21, 2015
Six Months of Hydroxyurea Reduces Albuminuria in Patients with Sickle Cell DiseasePablo Bartolucci, Anoosha Habibi, Thomas Stehlé, et al.
Regenerative Medicine Research|December 11, 2019
Matrix therapy is a cost-effective solution to reduce amputation risk and improve quality of life: pilot and case studiesPascal Desgranges, Taina Louissaint, Bertrand Godeau, et al.
Clinical Interventions in Aging|February 2, 2023
Older Adults and Immune Thrombocytopenia: Considerations for the ClinicianEtienne Crickx, Matthieu Mahévas, Marc Michel, et al.
La Revue De Medecine Interne|July 3, 2024
The CARMEN-France registry of adult patients with immune thrombocytopenia and autoimmune hemolytic anemia in FranceGuillaume Moulis, Marc Michel, Bernard Bonnotte, et al.
Joint Bone Spine|March 18, 2023
Severe immune thrombocytopenia in two patients with systemic sclerosisGonçalo Boleto, Jérôme Avouac, Bertrand Godeau, et al.
Haematologica|January 13, 2022
Effects of corticosteroids in patients with sickle cell disease and acute complications: a systematic review and meta-analysisJulien Lopinto, Segolene Gendreau, Enora Berti, et al.
Stroke|July 16, 2015
First Ischemic Stroke in Sickle-Cell Disease: Are There Any Adult Specificities?David Calvet, Françoise Bernaudin, Antoine Gueguen, et al.
Blood Advances|March 2, 2021
Whole-blood phenotyping to assess alloimmunization status in transfused sickle cell disease patientsMarie Tamagne, Sadaf Pakdaman, Pablo Bartolucci, et al.
Haematologica|March 16, 2023
Severity and burden of sickle cell disease in France: a nationwide real-world studyValentine Brousse, Francoise Bernaudin, Asma Melaine, et al.
Haematologica|May 8, 2025
Evaluating the safety profile of defibrotide in sickle cell disease: an in vitro studyLaura Bencheikh, Meghan Perkins, Kim Anh Nguyen, et al.
Pageof 27